Affiliation:
1. Almazov National Medical Research Center
2. Pavlov First Saint Petersburg State Medical University
3. University of Milan
Abstract
Current guidelines for the management of patients with dyslipidemia are well known and easily accessible. Despite this, according to research data based on actual clinical practice, selection of optimal tactics for managing patients with dyslipidemia often causes difficulties and leads to a failure to achieve the target levels. Tools such as clinical decision support system (CDSS) can help clinicians follow current clinical guidelines, taking into account the diversity of phenotypic profiles and side effects. This review highlights the effectiveness of CDSS implementation in medical practice as a means for making decisions in managing patients with dyslipidemia, as well as presents the algorithm for CDSS for lipid metabolism disorders created by specialists of the Almazov National Medical Research Center and the University of Milan.
Subject
Cardiology and Cardiovascular Medicine
Reference15 articles.
1. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670-81. doi:10.1016/S0140-6736(10)61350-5.
2. Atherosclerosis and dyslipidemia. Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations, VII revision. 2020;1(38):7-42. (In Russ.) doi:10.34687/2219-8202.JAD.2020.01.0002.
3. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Russian Journal of Cardiology. 2020;25(5):3826. (In Russ.) doi:10.15829/1560-4071-2020-3826.
4. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Russian Journal of Cardiology. 2017;(5):7-77. (In Russ.) doi:10.15829/1560-4071-2017-5-7-77.
5. Ray KK, Molemans B, Schoonen WM. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study, European Journal of Preventive Cardiology. 2020;zwaa047. doi:10.1093/eurjpc/zwaa047.